India · Delayed Price · Currency is INR Global Health Statistics
Total Valuation
Global Health has a market cap or net worth of INR 387.15 billion. The enterprise value is 386.86 billion.
| Market Cap | 387.15B |
| Enterprise Value | 386.86B |
Important Dates
The last earnings date was Tuesday, November 3, 2026.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | Aug 14, 2026 |
Share Statistics
Global Health has 268.87 million shares outstanding. The number of shares has increased by 0.14% in one year.
| Current Share Class | 268.87M |
| Shares Outstanding | 268.87M |
| Shares Change (YoY) | +0.14% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 43.79% |
| Owned by Institutions (%) | 23.84% |
| Float | 88.51M |
Valuation Ratios
The trailing PE ratio is 62.71 and the forward PE ratio is 45.20. Global Health's PEG ratio is 1.87.
| PE Ratio | 62.71 |
| Forward PE | 45.20 |
| PS Ratio | 7.66 |
| PB Ratio | 8.91 |
| P/TBV Ratio | 9.00 |
| P/FCF Ratio | 204.78 |
| P/OCF Ratio | 40.60 |
| PEG Ratio | 1.87 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 34.57, with an EV/FCF ratio of 204.63.
| EV / Earnings | 62.56 |
| EV / Sales | 7.66 |
| EV / EBITDA | 34.57 |
| EV / EBIT | 45.23 |
| EV / FCF | 204.63 |
Financial Position
The company has a current ratio of 2.72, with a Debt / Equity ratio of 0.31.
| Current Ratio | 2.72 |
| Quick Ratio | 2.50 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | 1.21 |
| Debt / FCF | 7.16 |
| Interest Coverage | 8.39 |
Financial Efficiency
Return on equity (ROE) is 15.23% and return on invested capital (ROIC) is 15.43%.
| Return on Equity (ROE) | 15.23% |
| Return on Assets (ROA) | 8.90% |
| Return on Invested Capital (ROIC) | 15.43% |
| Return on Capital Employed (ROCE) | 14.65% |
| Weighted Average Cost of Capital (WACC) | 5.51% |
| Revenue Per Employee | 4.01M |
| Profits Per Employee | 490,801 |
| Employee Count | 12,600 |
| Asset Turnover | 0.84 |
| Inventory Turnover | 30.15 |
Taxes
In the past 12 months, Global Health has paid 2.02 billion in taxes.
| Income Tax | 2.02B |
| Effective Tax Rate | 24.79% |
Stock Price Statistics
The stock price has increased by +22.76% in the last 52 weeks. The beta is 0.23, so Global Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.23 |
| 52-Week Price Change | +22.76% |
| 50-Day Moving Average | 1,368.34 |
| 200-Day Moving Average | 1,254.82 |
| Relative Strength Index (RSI) | 66.38 |
| Average Volume (20 Days) | 307,997 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Global Health had revenue of INR 50.53 billion and earned 6.18 billion in profits. Earnings per share was 22.96.
| Revenue | 50.53B |
| Gross Profit | 26.17B |
| Operating Income | 8.55B |
| Pretax Income | 8.15B |
| Net Income | 6.18B |
| EBITDA | 10.93B |
| EBIT | 8.55B |
| Earnings Per Share (EPS) | 22.96 |
Balance Sheet
The company has 14.01 billion in cash and 13.53 billion in debt, with a net cash position of 481.13 million or 1.79 per share.
| Cash & Cash Equivalents | 14.01B |
| Total Debt | 13.53B |
| Net Cash | 481.13M |
| Net Cash Per Share | 1.79 |
| Equity (Book Value) | 43.43B |
| Book Value Per Share | 160.85 |
| Working Capital | 13.21B |
Cash Flow
In the last 12 months, operating cash flow was 9.54 billion and capital expenditures -7.65 billion, giving a free cash flow of 1.89 billion.
| Operating Cash Flow | 9.54B |
| Capital Expenditures | -7.65B |
| Depreciation & Amortization | 2.37B |
| Net Borrowing | 2.10B |
| Free Cash Flow | 1.89B |
| FCF Per Share | 7.03 |
Margins
Gross margin is 51.80%, with operating and profit margins of 16.93% and 12.24%.
| Gross Margin | 51.80% |
| Operating Margin | 16.93% |
| Pretax Margin | 16.13% |
| Profit Margin | 12.24% |
| EBITDA Margin | 21.63% |
| EBIT Margin | 16.93% |
| FCF Margin | 3.74% |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.03%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 0.03% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 3.78% |
| FCF Payout Ratio | 7.11% |
| Buyback Yield | -0.14% |
| Shareholder Yield | -0.10% |
| Earnings Yield | 1.59% |
| FCF Yield | 0.49% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for Global Health is 1,652.16, which is 14.74% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 1,652.16 |
| Price Target Difference | 14.74% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 19 |
| Revenue Growth Forecast (3Y) | 18.06% |
| EPS Growth Forecast (3Y) | 26.57% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |